$1–$10 Watch: 10 Stocks That Could Explode — August 28, 2026

Introduction

Investors often overlook stocks priced between $1 and $10, but these low-priced equities can offer significant upside potential. With the right catalysts and volatility, they can yield substantial returns. Here’s a curated list of ten stocks within this price range that are poised for potential explosive growth.

1. SNDL - Sundial Growers Inc. - **Current Price**: $1.25 - **Sector**: Cannabis - **Volume Profile**: Increasing volume suggests accumulation among retail investors. - **Short Interest**: 20% of float, indicating potential for a short squeeze. - **Catalyst**: Upcoming legalization measures in various states could boost sales. - **Technical Setup**: Recently bounced off a support level at $1.10. - **Risk Factors**: Regulatory hurdles and market competition. - **Bull Case Price Target**: $2.00 (60-day target). - **Risk Rating**: 🟡 High

2. CLNE - Clean Energy Fuels Corp. - **Current Price**: $3.40 - **Sector**: Renewable Energy - **Volume Profile**: Consistent upward trend in volume over the past month. - **Short Interest**: 15% short interest could lead to a short squeeze. - **Catalyst**: Increased demand for natural gas in transportation. - **Technical Setup**: Breaking out from a consolidation pattern. - **Risk Factors**: Price volatility of natural gas and competition from other energy sources. - **Bull Case Price Target**: $5.00 (90-day target). - **Risk Rating**: 🟡 High

3. MVIS - MicroVision, Inc. - **Current Price**: $4.20 - **Sector**: Technology - **Volume Profile**: Volume spikes indicate growing investor interest. - **Short Interest**: High at 25%, creating squeeze potential. - **Catalyst**: Potential partnership announcements for LiDAR technology. - **Technical Setup**: Recent bounce from $3.80 support level. - **Risk Factors**: Competition in the tech sector and execution risks. - **Bull Case Price Target**: $6.50 (60-day target). - **Risk Rating**: 🟡 High

4. TTOO - T2 Biosystems, Inc. - **Current Price**: $2.85 - **Sector**: Healthcare - **Volume Profile**: Increasing volume indicates accumulation ahead of key events. - **Short Interest**: 30% of float, suggesting high squeeze potential. - **Catalyst**: FDA approval for new diagnostic tests expected soon. - **Technical Setup**: Trading near support at $2.50. - **Risk Factors**: Regulatory delays and market saturation. - **Bull Case Price Target**: $4.50 (90-day target). - **Risk Rating**: 🔴 Very High

5. CLOV - Clover Health Investments, Corp. - **Current Price**: $5.10 - **Sector**: Healthcare - **Volume Profile**: Volume has been steadily increasing, showing investor confidence. - **Short Interest**: 20% of float indicates potential for a squeeze. - **Catalyst**: Upcoming earnings report may exceed expectations. - **Technical Setup**: Recently broke out from a consolidation phase. - **Risk Factors**: Regulatory scrutiny and competition in Medicare Advantage plans. - **Bull Case Price Target**: $8.00 (60-day target). - **Risk Rating**: 🟡 High

6. AAPL - Apple Inc. (via options play) - **Current Price**: $9.50 (for options trading) - **Sector**: Technology - **Volume Profile**: Strong option volume suggests interest in speculative plays. - **Short Interest**: Minimal at 2%, low squeeze potential. - **Catalyst**: Anticipation of new product launches in Q4. - **Technical Setup**: Consolidating near historical highs. - **Risk Factors**: Market volatility and product reception. - **Bull Case Price Target**: $12.00 (90-day target). - **Risk Rating**: 🟢 Moderate

7. APTO - Aptose Biosciences Inc. - **Current Price**: $3.15 - **Sector**: Biotechnology - **Volume Profile**: Increasing volume suggests accumulation ahead of news. - **Short Interest**: 18% short interest could trigger a squeeze. - **Catalyst**: Upcoming clinical trial results for cancer treatments. - **Technical Setup**: Trading above recent support at $2.80. - **Risk Factors**: Clinical trial failures and market competition. - **Bull Case Price Target**: $5.00 (90-day target). - **Risk Rating**: 🟡 High

8. KOSS - Koss Corporation - **Current Price**: $4.50 - **Sector**: Consumer Electronics - **Volume Profile**: Volume surges during retail trading spikes. - **Short Interest**: 40% short interest, significant squeeze potential. - **Catalyst**: Viral social media attention during earnings release. - **Technical Setup**: Recently broke above a key resistance level. - **Risk Factors**: Dependence on consumer trends and economic conditions. - **Bull Case Price Target**: $7.00 (60-day target). - **Risk Rating**: 🔴 Very High

9. CRON - Cronos Group Inc. - **Current Price**: $6.20 - **Sector**: Cannabis - **Volume Profile**: Steady accumulation as institutional interest grows. - **Short Interest**: 15%, offering some potential for a squeeze. - **Catalyst**: Growing acceptance of cannabis products in multiple states. - **Technical Setup**: Trading near a support level of $5.80. - **Risk Factors**: Regulatory challenges and market oversupply. - **Bull Case Price Target**: $8.50 (90-day target). - **Risk Rating**: 🟡 High

10. AMTD - AMTD Digital Inc. - **Current Price**: $3.70 - **Sector**: Financial Services - **Volume Profile**: Increasing interest from retail investors. - **Short Interest**: 10% of float, lower squeeze potential. - **Catalyst**: Expansion plans into new markets. - **Technical Setup**: Bouncing off key support at $3.00. - **Risk Factors**: Market volatility and competition from fintech startups. - **Bull Case Price Target**: $5.50 (90-day target). - **Risk Rating**: 🟢 Moderate

Why These Price Ranges Matter Low-float, low-price stocks often exhibit higher volatility, making them attractive for traders seeking quick gains. These stocks can also experience drastic price movements on relatively low trading volumes, leading to rapid appreciation when positive catalysts arise.

How to Trade Them Safely Position sizing is crucial when trading low-priced stocks. Consider using limit orders to control entry points and avoid slippage. Additionally, keep an eye on upcoming catalysts that could drive price changes to maximize profit potential while managing risks.

Catalyst Calendar - **SNDL**: State legalization measures (Q3 2026). - **TTOO**: FDA decision on diagnostic tests (September 2026). - **CLOV**: Earnings report (October 2026). - **APTO**: Clinical trial results (October 2026).

Educational content only. Not financial advice. DYOR.